• 1
    Thamm DH, Vail DM. Mast cell tumors. In: WithrowSJ, MacEwenEG, eds. Small Animal Clinical Oncology, 4th ed. Philadelphia, PA: WB Saunders Co; 2007:402424.
  • 2
    London CA, Seguin B. Mast cell tumors in the dog. Vet Clin North Am Small Anim Pract 2003;33:473489.
  • 3
    Misdorp W. Mast cells and canine mast cell tumors. A review. Vet Q 2004;26:156159.
  • 4
    Gieger T, Northrup N, Wall M. Clinical management of mast cell tumors in dogs. Compend Contin Educ Pract Vet 2005;27:5668.
  • 5
    Weisse C, Shofer FS, Sorenmo K. Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision. J Am Anim Hosp Assoc 2002;38:7173.
  • 6
    OwenLN, ed. TNM Classification of Tumours in Domestic Animals, 1st ed. Geneva: World Health Organization; 1980:1415.
  • 7
    Gieger TL, Theon AP, Werner JA, et al. Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 cases (1990–2001). J Vet Intern Med 2003;17:687692.
  • 8
    Finora K, Leibman NF, Fettman MJ, et al. Cytological comparison of fine-needle aspirates of liver and spleen of normal dogs and of dogs with cutaneous mast cell tumours and an ultrasonographically normal appearing liver and spleen. Vet Comp Oncol 2006;4:178183.
  • 9
    Seguin B, Faulkner Besancon M, McCallan JL, et al. Recurrence rate, clinical outcome, and cellular proliferation indices as prognostic indicators after incomplete surgical excision of cutaneous Grade II mast cell tumors: 28 dogs (1994–2002). J Vet Intern Med 2006;20:933940.
  • 10
    Marconato L, Bettini G, Giacoboni C, et al. Clinicopathological features and outcome for dogs with mast cell tumors and bone marrow involvement. J Vet Intern Med 2008;22:10011007.
  • 11
    McManus PM. Frequency and severity of mastocytemia in dogs with and without mast cell tumors: 120 cases (1995–1997). J Am Vet Med Assoc 1999;215:355357.
  • 12
    Cayette SM, McManus PM, Miller WH JR, et al. Identification of mast cells in buffy coat preparations from dogs with inflammatory skin diseases. J Am Vet Med Assoc 1995;206:325326.
  • 13
    Patnaik AK, Ehler WJ, MacEwen EG. Canine cutaneous mast cell tumor: Morphologic grading and survival time in 83 dogs. Vet Pathol 1984;21:469474.
  • 14
    Crivellato E, Beltrami CA, Mallardi F, et al. The mast cell: An active participant or an innocent bystander? Histol Histopathol 2004;19:259270.
  • 15
    Raskin R, Meyer DJ. Lymphoid system. In: Atlas of Canine and Feline Cytology, 1st ed. Philadelphia, PA: WB Saunders Co; 2001:93134.
  • 16
    O'Keefe DA, Couto CG, Burke-Schwartz C, et al. Systemic mastocytosis in 16 dogs. J Vet Intern Med 1987;1:7580.
  • 17
    Baker-Gabb M, Hunt GB, France MP. Soft tissue sarcomas and mast cell tumours in dogs; clinical behaviour and response to surgery. Aust Vet J 2003;81:732738.
  • 18
    Dobson JM, Scase TJ. Advances in the diagnosis and management of cutaneous mast cell tumors in dogs. J Small Anim Pract 2007;48:424431.
  • 19
    Ishiguro T, Kadosawa T, Takagi S, et al. Relationship of disease progression and plasma histamine concentrations in 11 dogs with mast cell tumors. J Vet Intern Med 2003;17:194198.
  • 20
    Hahn KA, King GK, Carreras JK. Efficacy of radiation therapy for incompletely resected grade-III mast cell tumors in dogs: 31 cases (1987–1998). J Am Vet Med Ass 2004;224:7982.
  • 21
    Camps-Palau MA, Leibman NF, Elmslie R, et al. Treatment of canine mast cell tumours with vinblastine, cyclophosphamide and prednisone: 35 cases (1997–2004). Vet Comp Oncol 2007;5:156167.
  • 22
    Ballegeer EA, Forrest LJ, Dickinson RM, et al. Correlation of ultrasonographic appearance of lesions and cytologic and histologic diagnoses in splenic aspirates from dogs and cats: 32 cases (2002–2005). J Am Vet Med Assoc 2007;230:690696.
  • 23
    Stockhaus C, Van Den Ingh T, Rothuizen J, et al. A multistep approach in the cytologic evaluation of liver biopsy samples of dogs with hepatic diseases. Vet Pathol 2004;41:461470.
  • 24
    Levi-Schaffer F, Rubinchik E. Mast cell role in fibrotic disease. Isr J Med Sci 1998;31:450453.
  • 25
    Thamm DH, Mauldin EA, Vail DM. Outcome and prognostic factors following adjuvant prednisone/vinblastine chemotherapy for high risk canine mast cell tumor: 61 cases. J Vet Med Sci 2006;68:581587.
  • 26
    Sato AF, Solano M. Ultrasonographic findings in abdominal mast cell disease: A retrospective study of 19 patients. Vet Radiol Ultrasound 2004;45:5157.
  • 27
    Faverzani S, Chinosi S, Valenti P, et al. Comparison between ultrasonography and cytology of liver focal lesions and parenchyma in the dog and cat. Vet Res Commun 2006;30:293296.
  • 28
    Wang KY, Panciera DL, Al-Rukibat RK, et al. Accuracy of ultrasound-guided fine-needle aspiration of the liver and cytologic findings in dogs and cats: 97 cases (1990–2000). J Am Vet Med Assoc 2004;224:7578.
  • 29
    Léveillé R, Partington BP, Biller DS, et al. Complications after ultrasound-guided biopsy of abdominal structures in dogs and cats: 246 cases (1984–1991). J Am Vet Med Assoc 1993;203:413415.
  • 30
    Meyer DJ. The essentials of diagnostic cytology in clinical oncology. In: WithrowSJ, MacEwenE3rd, eds. Small Animal Clinical Oncology. New York: WB Saunders; 2001:5462.
  • 31
    Mullins MN, Dernell WS, Withrow SJ, et al. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998–2004). J Am Vet Med Ass 2006;228:9195.
  • 32
    Murphy S, Sparkers AH, Smith KC, et al. Relationships between the histological grade of cutaneous mast cell tumours in dogs, their survival and the efficacy of surgical resection. Vet Rec 2004;154:743746.
  • 33
    Scase TJ, Edwards D, Miller J, et al. Canine mast cell tumors: Correlation of apoptosis and proliferation markers with prognosis. J Vet Intern Med 2006;20:151158.
  • 34
    Abadie J.J, Amardeilh M.A, Delverdier ME. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs. J Am Vet Med Assoc 1999;215:16291634.
  • 35
    Seguin B, Leibman NF., Bregazzi VS, et al. Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996–1999). J Am Vet Med Assoc 2001;218:11201123.
  • 36
    Jaffe MH, Hosgood G, Taylor HW, et al. Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumors. Vet Pathol 2000;37:4046.
  • 37
    Sfiligoi G, Rassnick KM, Scarlett JM, et al. Outcome of dogs with mast cell tumors in the inguinal or perineal region versus other cutaneous locations: 124 cases (1990–2001). J Am Vet Med Assoc 2005;226:13681374.
  • 38
    Murphy S, Sparkers AH, Blunden AS, et al. Effects of stage and number of tumours on prognosis of dogs with cutaneous mast cell tumours. Vet Rec 2006;158:287291.
  • 39
    Gerritsen RJ, Teske E, Kraus JS, et al. Multi-agent chemotherapy for mast cell tumours in the dog. Vet Q 1998;20:2831.
  • 40
    Thamm DH, Mauldin EA, Vail DM. Prednisone and vinblastine chemotherapy for canine mast cell tumor—41 cases (1992–1997). J Vet Intern Med 1999;13:491497.
  • 41
    Turrel JM, Kitchell BE, Miller LM, et al. Prognostic factors for radiation treatment of mast cell tumor in 85 dogs. J Am Vet Med Assoc 1988;193:936940.